PDCD1 PD-1.3 polymorphism and allergic bronchial asthma in Russian and Buryat patients

References

• Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996;8:765–772.
   PubMed Web of Science ®Google Scholar
• Lombardi V, Singh AK, Akbari O. The role of costimulatory molecules in allergic disease and asthma. Int Arch Allergy Immunol 2010;151(3):179–189.
   PubMed Web of Science ®Google Scholar
• Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999;5:1365–1369.
   PubMed Web of Science ®Google Scholar
• Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000;192:1027–1034.
   PubMed Web of Science ®Google Scholar
• Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001;2:261–268.
   PubMed Web of Science ®Google Scholar
• Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 2010;236:219–242.
   PubMed Web of Science ®Google Scholar
• Fife BT, Pauken KE. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Ann N Y Acad Sci 2011;1217:45–59.
   PubMed Web of Science ®Google Scholar
• Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004;4:336–347.
   PubMed Web of Science ®Google Scholar
• Singh AK, Stock P, Akbari O. Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy 2011;66(2):155–162.
   PubMed Web of Science ®Google Scholar
• Lewkowich IP, Lajoie S, Stoffers SL, Suzuki Y, Richgels PK, Dienger K, Sproles AA et al. PD-L2 modulates asthma severity by directly decreasing dendritic cell IL-12 production. Mucosal Immunol 2013;6(4):728–739.
   PubMed Web of Science ®Google Scholar
• McAlees JW, Lajoie S, Dienger K, Sproles AA, Richgels PK, Yang Y, Khodoun M et al. Differential control of CD4+ T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthma. Eur J Immunol 2015;45(4):1019–1029.
   PubMed Web of Science ®Google Scholar
• Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nature Genet 2002;32:666–669.
   PubMed Web of Science ®Google Scholar
• Wang SC, Chen YJ, Ou TT, Wu CC, Tsai WC, Liu HW, Yen JH. Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan. J Clin Immunol 2006;26(6):506–511.
   PubMed Web of Science ®Google Scholar
• Prokunina L, Padyukov L, Bennet A, de Faire U, Wiman B, Prince J, Alfredsson L et al. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum 2004;50(6):1770–1773.
   PubMed Web of Science ®Google Scholar
• Prokunina L, Gunnarsson I, Sturfelt G, Truedsson L, Seligman VA, Olson JL, Seldin MF et al. The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum 2004;50(1):327–328.
   PubMed Web of Science ®Google Scholar
• Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Maurer M, Wiendl H et al. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 2005;58:50–57.
   PubMed Web of Science ®Google Scholar
• Asgari N, Nielsen C, Stenager E, Kyvik KO, Lillevang ST. HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica. Mult Scler 2012;18(1):23–30.
   PubMed Web of Science ®Google Scholar
• Lee SH, Lee YA, Woo DH, Song R, Park EK, Ryu MH, Kim YH et al. Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population. Arthritis Res Ther 2006;8(6): R163.
   PubMed Web of Science ®Google Scholar
• Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST. Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 2003;62(6):492–497.
   PubMedGoogle Scholar
• Lin SC, Yen JH, Tsai JJ, Tsai WC, Ou TT, Liu HW, Chen CJ. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 2004;50(3):770–775.
   PubMed Web of Science ®Google Scholar
• Johansson M, Arlestig L, Moller B, Rantapaa-Dahlqvist S. Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus. Arthritis Rheum 2005;52(6):1665–1669.
   PubMed Web of Science ®Google Scholar
• Soleimanifar N, Amirzargar AA, Mahmoudi M, Pourfathollah AA, Azizi E, Jamshidi AR, et al. Study of programmed cell death 1 (PDCD1) gene polymorphims in Iranian patients with ankylosing spondylitis. Inflammation 2011;34(6):707–712.
   PubMed Web of Science ®Google Scholar
• Yang M, Zou Y, Bai Y, Li M. The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis. J Orthop Sci 2015;20(1):55–63.
   PubMed Web of Science ®Google Scholar
• Asad S, Nikamo P, Torn C, Landin-Olsson M, Lernmark A, Alarcon-Riquelme M, et al. No evidence of association of the PDCD1 gene with Type 1 diabetes. Diabet Med 2007;24(12):1473–1477.
   PubMed Web of Science ®Google Scholar
• FitzGerald M, Bateman ED, Boulet LP, Cruz A, Haahtela T, Levy M, O'Byrne P, et al. Pocket guide for asthma management and prevention for adults and children older than 5 years. Global Initiative for Asthma (GINA). 2012. Available from: http://www.ginasthma.org/local/uploads/files/GINA_Pocket2013_May15_1.pdf.
   Google Scholar
• Kong EK, Prokunina-Olsson L, Wong WH, Lau CS, Chan TM, Alarcуn-Riquelme M, Lau YL. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 2005;52(4):1058–1062.
   PubMed Web of Science ®Google Scholar
• Liu X, Hu LH, Li YR, Chen FH, Ning Y, Yao QF. Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population. Rheumatol Int 2011;31(2):209–213.
   PubMed Web of Science ®Google Scholar
• Liu C, Jiang J, Gao L, Hu X, Wang F, Shen Y, et al. A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the Han Chinese population of southeastern China. Int J Genomics 2014;247637.
   PubMed Web of Science ®Google Scholar
• Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F, et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum 2004;50(8):2590–2597.
   PubMed Web of Science ®Google Scholar
• Deppong C, Juehne TI, Hurchla M, Friend LD, Shah DD, Rose CM, et al. Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J Immunol 2006;176(7):3909–3913.
   PubMed Web of Science ®Google Scholar
• McGee HS, Yagita H, Shao Z, Agrawal DK. Programmed death-1 antibody blocks therapeutic effects of T-regulatory cells in cockroach antigen-induced allergic asthma. Am J Respir Cell Mol Biol 2010;43:432–442.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Inoue H, Nakano T, Tsuda M, Yoshiura Y, Fukuyama S, et al. B7-DC regulates asthmatic response by an IFNgamma-dependent mechanism. J Immunol 2004;172:2530–2541.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan S, Iijima K, Kobayashi T, Rodriguez M, Kita H, Pease LR. Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibody. J Immunol 2004;173(2):1360–1365.
   PubMed Web of Science ®Google Scholar
• Akbari O, Stock P, Singh AK, Lombardi V, Lee WL, Freeman GJ, Sharpe AH, et al. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol 2010;3(1):81–91.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chung Y, Bishop C, Daugherty B, Chute H, Holst P, et al. Regulation of T cell activation and tolerance by PDL2. Proc Natl Acad Sci U S A 2006;103(31):11695–11700.
   PubMed Web of Science ®Google Scholar
• Zhao J, Lloyd CM, Noble A. Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling. Mucosal Immunol 2013;6(2):335–346.
   PubMed Web of Science ®Google Scholar
• Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. Th17 cells: new players in asthma pathogenesis. Allergy 2011;66(8):989–998.
   PubMed Web of Science ®Google Scholar
• Kristjansdottir H, Steinsson K, Gunnarsson I, Grondal G, Erlendsson K, Alarcon-Riquelme ME. Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus. Arthritis Rheum 2010;62(6):1702–1711.
   PubMed Web of Science ®Google Scholar
• Har'kov VN, Hamina KV, Medvedeva OF, Simonova KV, Eremina ER, Stepanov VA. Gene pool of Buryats: clinal variability and territorial subdivision based on data of Y-chromosome markers. Genetika 2014;50(2):203–213.
   PubMedGoogle Scholar
• Zhao Y, Yang J, Gao YD, Guo W. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol 2010;151(4):297–307.
   PubMed Web of Science ®Google Scholar
• Albano GD, Sano CD, Bonanno A, Riccobono L, Gagliardo R, Chanez P, et al. Th17 immunity in children with allergic asthma and rhinitis: a pharmacological approach. PLoS One 2013;8(4):58892.
   Web of Science ®Google Scholar
• Bottema RWB, Postma DS, Rejmerink NE, Tijs C, Stelma FF, Smit HA. Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE. Eur Respir J 2010;35:54–63.
   PubMed Web of Science ®Google Scholar
• Bertsias GK, Nakou M, Choulaki C, Raptopoulou A, Papadimitraki E, Goulielmos G. Genetic, immunologic, and immunohistochemical analysis of the programmed death1/programmed death ligand 1 pathwayin human systemic lupus erythematosus. Arthritis Rheum 2009;60:207–218.
   PubMed Web of Science ®Google Scholar
• Braun-Prado K, Petzl-Erler ML. Programmed cell death 1 gene (PDCD1) polymorphism and pemphigus foliaceus (fogo selvagem) disease susceptibility. Genetics and Molecular Biology 2007;30(2):314–321.
   Web of Science ®Google Scholar